The combination of the Coronavirus (COVID-19) pandemic and the imminent end of the Brexit transition period means a fast-changing regulatory environment for medicines. In October 2020, the UK Government made changes to the regulation of medicines for COVID-19 and influenza. The regulations set out changes for the temporary authorisation of medicines (including COVID-19 vaccines) and […]

The post Brexit and COVID-19: Changes to the Regulation of Medicines appeared first on EMPLOYEE BENEFITS BLOG.

https://www.employeebenefitsblog.com/2021/04/brexit-and-covid-19-changes-to-the-regulation-of-medicines/

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply